Award Notice
1 notice
1 document
6505--Lenalidomide VISN 22 BPA 36C26226Q0097
Posted
Jan 13, 2026
Deadline
No deadline
Set-aside
None
NAICS
325412
PSC
6505
Summary
AI-generated · Jan 14, 2026Lenalidomide under the VISN 22 Blanket Purchase Agreement has been awarded to Exelan Pharmaceuticals Inc., with a total value of $21,167,021.
The award establishes a BPA-based supply arrangement for Lenalidomide for VISN 22 facilities; no additional solicitation details are provided in this notice.
Notice history
1-
Award Notice LATEST Posted Jan 13, 2026
Details
Award Information
Awardee
1
Total Awarded
$21,167,021.00
Award Date
Jan 13, 2026
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| EXELAN PHARMACEUTICALS INC | FYZXNHSQTMG8 | 6GFC4 | BOCA RATON |
Contacts
primary
Email
Hestia Sim
Contract Specialist
Agency
VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
262-NETWORK CONTRACT OFFICE 22 (36C262)
Place of Performance
Dates
Posted
Jan 13, 2026
6 months ago
Last Updated
Aug 06, 2026
2 days ago
Awarded
Jan 13, 2026
6 months ago